We still need content for "Use Cases and Success Stories" and "Outlook and Perspective".
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
Originally posted by robs View PostSeems like Joann removed mine as well. I assumed that the removal of my edits was by accident and added them again.
Comment
-
Originally posted by robs View PostWe still need content for "Use Cases and Success Stories" and "Outlook and Perspective".
On the other hand, if there is a decision to include accurate details on the country participation to illustrate the support for open science demonstrated here, I would suggest that SEQanswers/authors propose undertaking periodic updates of this metric to enable longer term scientometric monitoring for the growth and expansion of open science and issue an invite to other open science platforms to do the same. This would have particular weight since it has been easy to recognize on this forum the signficance of international contributors who have added to the US-UK 50% bar in figure 3
Depending on the length of the article and with additional material, this report may be suitable as a regular contribution to Science rather than a letter.
Comment
-
-
Originally posted by robs View PostSeems like we are stuck right now. There were no changes over the last week.
Could you figure out which part you will be able to work on and which one I should try to tackle next?
GDoc tracks changes just like a wiki and we can even highlight each contribution with a different highlight color. Besides the key contributors are rather clear at this point anyways....
Comment
-
Originally posted by Joann View PostHow long will this paper be? I'd like to include an entire section on open access with some comparative data if there'd be room.
Is there a link to the googledoc?
Send me a PM and I will send you a link today as soon as I finish it.
Comment
-
I was trying to find time to add in my edits but it will probably be a couple more days. However I do not want to hold back Marco and Rob and others, so here is the link:
The document is at least now formatted in such a way that we can export and submit directly to the journal. I put the authors that were in the wiki but people should add themselves if I missed someone. Also feel free to change the order.
I shorten the abstract because we only get 200 words (so far it is 144). The remainder of the abstract text was moved to the body not because it flows well but because I did not want to delete it.
Rob should add in the two figures he made. They are great. And we should put in figure legends. People can list references as PUBMED IDs or if they want full text citations. It does not matter though because I will convert it all to endnote before we submit.
With a little bit of formatting and editing, I think we can put this all together next week... I will post my changes by Monday.
Comment
Latest Articles
Collapse
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 06:25 AM
|
0 responses
13 views
0 likes
|
Last Post
by seqadmin
Today, 06:25 AM
|
||
Started by seqadmin, Yesterday, 01:02 PM
|
0 responses
12 views
0 likes
|
Last Post
by seqadmin
Yesterday, 01:02 PM
|
||
Started by seqadmin, 09-18-2024, 06:39 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-18-2024, 06:39 AM
|
||
Started by seqadmin, 09-11-2024, 02:44 PM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-11-2024, 02:44 PM
|
Comment